| Execution period | 1 April 2027 for 60 months |
|---|
BSE filing, NSE: GLAXO. Summary written from the filing by ALFA Finder's alert engine.
GlaxoSmithKline Pharmaceuticals Ltd: key numbers
- Share price
- ₹2,575.10
- Market cap
- ₹43,624 Cr
- Revenue (annual)
- ₹3,822 Cr
- Net profit (annual)
- ₹1,036 Cr
- P/E (TTM)
- 40.8×Sector 47.2×
- Promoter holding
- 75.00%+0.00% QoQ
- FII holding
- 4.75%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from GlaxoSmithKline Pharmaceuticals Ltd
All →GlaxoSmithKline Pharmaceuticals Management Change
GlaxoSmithKline Pharmaceuticals appointed Sandeep Seth as Head - Ethics & Compliance, effective 3 November 2026. He brings over 20 years of compliance and governance experience.
GlaxoSmithKline Pharmaceuticals Results Update
GSK Pharmaceuticals reported Q2 FY27 media release showing revenue of INR 1180 crore (up 21%) and PAT of INR 335 crore (up 31%). The release also announces the upcoming BLENREP launch in India.
GlaxoSmithKline Pharmaceuticals Q2 FY27 Results: Net Profit ₹335.9 Cr, Up 30.4% YoY
GlaxoSmithKline Pharmaceuticals Ltd reported revenue from operations of ₹1,184 Cr (+20.8% YoY) and net profit of ₹335.9 Cr (+30.4% YoY) for Q2 FY27.
- Key figure
- Net profit ₹335.9 Cr · +30.4% YoY
GlaxoSmithKline Pharmaceuticals Board Meeting Date
GlaxoSmithKline Pharmaceuticals Limited will hold a board meeting on 3rd November 2026 to consider and approve its unaudited financial results for the quarter ended 30th September 2026.
GlaxoSmithKline Pharmaceuticals Other Announcement
GlaxoSmithKline Pharmaceuticals Ltd has filed its quarterly shareholding pattern for the quarter ended September 30, 2026, as required by SEBI listing regulations.
GlaxoSmithKline Pharmaceuticals Annual General Meeting
GSK Pharma's postal ballot approved Ms. Natland as NED and Mr. Akshikar's MD re-appointment. Both resolutions cleared with over 99% shareholder support.
Other other announcement announcements
All →Timex Group India Other Announcement
Timex Group India appointed B S R & Co. LLP as statutory auditor, effective August 10, 2027. The board approved it at a November 3, 2026 meeting.
- Execution
- 60 months
Manipal Payment and Identity Solutions Other Announcement
Manipal Payment and Identity Solutions authorised CFO Ramanath Pai to determine material events under SEBI LODR. The board reviewed its materiality policy today.
Hardwyn India Other Announcement
Hardwyn India appointed M/s. Amit H.V. & Associates as its Secretarial Auditor, effective 1 April 2025. The firm holds a valid peer review certificate.
Wendt (India) Other Announcement
Wendt (India) Limited informed exchanges that its RTA, KFin Technologies, is shifting its corporate office to Kokapet, Hyderabad effective 1 December 2026. The registered office stays unchanged.
Windsor Machines Other Announcement
Windsor Machines filed ICRA's monitoring agency report on Preferential Issue proceeds for the quarter ended September 2026. The report confirms no deviation from the issue objects.
Indiqube Spaces Other Announcement
Indiqube Spaces submitted Crisil's monitoring agency report on IPO proceeds for the quarter ended September 30, 2026. The report flags utilisation deviation of 25-35%.